alexa Abstract | Impact of riboflavin-UVA-photodynamic inactivation (PDI) (collagen crosslinking technique) on viability, cell cycle phase, apoptosis and proliferation of human corneal endothelial cells

Journal of Chemical and Pharmaceutical Research
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Original Articles Open Access


The purpose of our study was to determine the impact of riboflavin-UVA photodynamic inactivation (PDI) (Collagen crosslinking technique) on viability, cell cycle phase, apoptosis and proliferation of human corneal endothelial cells (HCECs), in vitro. A HCEC line was cultured in DMEM/Ham's F12 medium supplemented with 5% fetal calf serum. HCECs cultures underwent 370 nm-UVA-light illumination for 4.1 minutes during exposure to 0.05% or 0.1% riboflavin and 20% dextran containing PBS. Twenty-four hours after riboflavin-UVA-PDI, viability was determined by the Alamar blue assay, cell cycle phase and apoptosis of the cells using the APO-DIRECTTM Kit, and two and twenty-four hours after PDI, HCECs proliferation by the BrdU Cell Proliferation Assay Kit. Twenty-four hours after the use of 0.1% riboflavin concentration without illumination and after 0.05% and 0.1% riboflavin-UVA-PDI, HCECs viability decreased significantly (P<0.01 for all) compared to controls. Twenty-four hours following riboflavin-UVA-PDI, the percentage of HCECs at the G1 cell cycle phase decreased significantly using 0.05% or 0.1% riboflavin concentration (P=0.02 and P=0.03), the percentage of HCECs at the G2/M phase increased significantly using 0.05% riboflavin concentration (P=0.03), compared to controls. Two and twenty-four hours after riboflavin-UVA-PDI using 0.05% or 0.1% riboflavin concentration, HCEC proliferation decreased significantly (P=0.02 for all). There was no significant difference in percentage of apoptotic HCECs at any of the treated groups compared to controls 24 hours after riboflavin-UVA-PDI (P=0.10).Crosslinking arrests HCECs at the G2/M phase, decreases viability and proliferation, however does not trigger apoptosis of human corneal endothelial cells in vitro.

To read the full article Peer-reviewed Article PDF image

Author(s): Jiong Wang Tanja StachonXuefei Song Timo Eppig Achim Langenbucher Berthold Seitz and Nra Szentmry


Riboflavin, UVA, human corneal endothelial cells, viability, apoptosis

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version